Alan D. Brown

2.2k total citations
68 papers, 1.5k citations indexed

About

Alan D. Brown is a scholar working on Organic Chemistry, Molecular Biology and Rheumatology. According to data from OpenAlex, Alan D. Brown has authored 68 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 14 papers in Molecular Biology and 11 papers in Rheumatology. Recurrent topics in Alan D. Brown's work include Pelvic floor disorders treatments (11 papers), Receptor Mechanisms and Signaling (6 papers) and Neuroendocrine regulation and behavior (6 papers). Alan D. Brown is often cited by papers focused on Pelvic floor disorders treatments (11 papers), Receptor Mechanisms and Signaling (6 papers) and Neuroendocrine regulation and behavior (6 papers). Alan D. Brown collaborates with scholars based in United Kingdom, United States and Canada. Alan D. Brown's co-authors include P.D. Wilson, Richard Warwick, David C. Blakemore, S. Skerratt, David C. Pryde, Edward B. Stevens, Sharan K. Bagal, Kiyoyuki Omoto, Richard Storer and Steven V. Ley and has published in prestigious journals such as PLoS ONE, Cancer Research and Chemical Communications.

In The Last Decade

Alan D. Brown

65 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Alan D. Brown 410 369 365 211 191 68 1.5k
Matthias Stahl 500 1.2× 166 0.4× 210 0.6× 317 1.5× 111 0.6× 60 2.1k
Misun Lee 343 0.8× 169 0.5× 241 0.7× 294 1.4× 106 0.6× 60 1.9k
Walter Kühn 326 0.8× 86 0.2× 58 0.2× 51 0.2× 164 0.9× 91 1.6k
Hidenori Mochizuki 531 1.3× 256 0.7× 53 0.1× 37 0.2× 60 0.3× 72 1.4k
Michael Holmes 683 1.7× 62 0.2× 68 0.2× 66 0.3× 197 1.0× 35 1.4k
John P. Long 592 1.4× 374 1.0× 119 0.3× 49 0.2× 281 1.5× 115 1.7k
Atsushi Kitamura 493 1.2× 90 0.2× 50 0.1× 38 0.2× 150 0.8× 105 1.4k
Antonio Guglietta 459 1.1× 344 0.9× 49 0.1× 24 0.1× 186 1.0× 65 1.7k
Victor A. Najjar 1.0k 2.5× 102 0.3× 147 0.4× 29 0.1× 289 1.5× 69 2.3k
Dianne Webster 889 2.2× 26 0.1× 116 0.3× 70 0.3× 109 0.6× 92 2.0k

Countries citing papers authored by Alan D. Brown

Since Specialization
Citations

This map shows the geographic impact of Alan D. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan D. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan D. Brown more than expected).

Fields of papers citing papers by Alan D. Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan D. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan D. Brown. The network helps show where Alan D. Brown may publish in the future.

Co-authorship network of co-authors of Alan D. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Alan D. Brown. A scholar is included among the top collaborators of Alan D. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan D. Brown. Alan D. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Alan D., Shajila Siricilla, Ronald McCarthy, et al.. (2025). Restricted mating windows and thrombospondin 2 gene deletion improve the precision of parturition timing in mice. Biology of Reproduction. 113(4). 886–893. 1 indexed citations
2.
Raveh, Adi, Alon Silberman, Asher Peretz, et al.. (2024). Dual Kv7.2/3-TRPV1 modulators inhibit nociceptor hyperexcitability and alleviate pain without target-related side effects. Pain. 166(4). 793–811. 2 indexed citations
3.
Brown, Alan D., et al.. (2013). Serendipity in drug-discovery: A new series of 2-(benzyloxy)benzamides as TRPM8 antagonists. Bioorganic & Medicinal Chemistry Letters. 23(22). 6118–6122. 10 indexed citations
4.
Pryde, David C., Lyn H. Jones, David Gervais, et al.. (2013). Selection of a Novel Anti-Nicotine Vaccine: Influence of Antigen Design on Antibody Function in Mice. PLoS ONE. 8(10). e76557–e76557. 66 indexed citations
5.
Brown, Alan D., et al.. (2010). UP-2.11: A comparative analysis of MiniArc™ and Monarc™ sub-urethral slings for female stress urinary incontinence. Urology. 76(3). S83–S83. 1 indexed citations
6.
Brown, Alan D., et al.. (2010). Identification of a urea bioisostere of a triazole oxytocin antagonist. Bioorganic & Medicinal Chemistry Letters. 20(6). 1851–1853. 9 indexed citations
7.
Brown, Alan D., et al.. (2010). Identification of amide bioisosteres of triazole Oxytocin antagonists. Bioorganic & Medicinal Chemistry Letters. 20(7). 2224–2228. 1 indexed citations
8.
Andrews, Mark D., et al.. (2009). Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: Part 2. Bioorganic & Medicinal Chemistry Letters. 19(20). 5893–5897. 3 indexed citations
9.
Andrews, Mark D., et al.. (2009). Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility Part 1. Bioorganic & Medicinal Chemistry Letters. 19(8). 2329–2332. 6 indexed citations
10.
Brown, Alan D., et al.. (2009). Triazole oxytocin antagonists: Identification of an aryloxyazetidine replacement for a biaryl substituent. Bioorganic & Medicinal Chemistry Letters. 20(2). 516–520. 62 indexed citations
11.
Andrews, Mark D., Charlotte Allerton, Julian Blagg, et al.. (2009). Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT2C agonists. Bioorganic & Medicinal Chemistry Letters. 19(18). 5346–5350. 5 indexed citations
12.
Miller, Duncan C., Wolfgang Klute, Andrew Calabrese, & Alan D. Brown. (2009). Optimising metabolic stability in lipophilic chemical space: The identification of a metabolically stable pyrazolopyrimidine CRF-1 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 19(21). 6144–6147. 16 indexed citations
13.
Brown, Alan D., et al.. (2008). Triazole oxytocin antagonists: Identification of aryl ether replacements for a biaryl substituent. Bioorganic & Medicinal Chemistry Letters. 18(19). 5242–5244. 17 indexed citations
14.
Brown, Alan D., et al.. (2008). Design and optimization of potent, selective antagonists of Oxytocin. Bioorganic & Medicinal Chemistry Letters. 18(15). 4278–4281. 12 indexed citations
15.
Brown, Alan D., Julian Blagg, & David S. Reynolds. (2007). Designing drugs for the treatment of female sexual dysfunction. Drug Discovery Today. 12(17-18). 757–766. 23 indexed citations
16.
Brown, Alan D., Mark E. Bunnage, Paul A. Glossop, et al.. (2007). The discovery of indole-derived long acting β2-adrenoceptor agonists for the treatment of asthma and COPD. Bioorganic & Medicinal Chemistry Letters. 17(22). 6188–6191. 22 indexed citations
17.
Brown, Alan D., et al.. (2006). Small molecule inhibitors of IgE synthesis. Bioorganic & Medicinal Chemistry Letters. 16(17). 4697–4699. 8 indexed citations
18.
Duggan, Paul, P.D. Wilson, Peggy Norton, et al.. (2003). Utilization of preoperative urodynamic investigations by gynecologists who frequently operate for female urinary incontinence. International Urogynecology Journal. 14(4). 282–287. 15 indexed citations
19.
Brown, Alan D.. (1999). Beyond Prostitution: Justice, Feminism, and Social Change. Canadian women's studies. 19(2). 1 indexed citations
20.
Brown, Alan D. & J. G. Robertson. (1968). THE ULTRASONIC DOPPLER CARDIOSCOPE IN OBSTETRICS. BJOG An International Journal of Obstetrics & Gynaecology. 75(1). 92–96. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026